Terms without borders: An international approach to terminology

Diagnostic Cytopathology

Volumn 33, Issue 5, 2005, Pages 352-355

  Herbert, Amanda ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cervical intraepithelial neoplasia (CIN); Dyskaryosis; Squamous intraepithelial lesion (SIL); The Bethesda System; The British Society for Clinical Cytology (BSCC) terminology

Indexed keywords

CELL NUCLEUS; COLPOSCOPY; CONFERENCE PAPER; CYTOPATHOLOGY; DYSKARYOSIS; HUMAN; NOMENCLATURE; PAPANICOLAOU TEST; PRECANCER; PRIORITY JOURNAL; SQUAMOUS INTRAEPITHELIAL LESION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX EPITHELIUM; WART VIRUS;

CARCINOMA IN SITU; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; EPITHELIAL CELLS; FEMALE; HUMANS; INTERNATIONAL COOPERATION; TERMINOLOGY; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 27744599731     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/dc.20294     Document Type: Conference Paper

References (17)

1. Solomon D, Nayar R. The Bethesda system for reporting cervical cytology: definitions, criteria and explanatory notes. 2nd ed. New York: Springer; 2003.
2. Herbert A. BSCC terminology for cervical cytology: two or three tiers? Why not five, seven or even fourteen? Cytopathology 2004;15:245-251.
3. Johnson J, Patnick J. Achievable standards, benchmarks for reporting and criteria for evaluating cervical cytopathology. 2nd ed. NHS Cancer Screening Programmes, 2000 (NHSCSP Publication No 1).
4. Mitchell MF, Tortelero-Luna G, Wright T, et al. Cervical human papillomavirus infection and intraepithelial neoplasia: a review. J Natl Cancer Inst Monogr 1996;21:17-25.
5. Holowaty P, Miller AB, Rohan T, To T. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 1999;91:200-201.
6. Peto J, Gilham C, Fletcher O, Matthews FE. The cervical epidemic that screening has prevented in the UK. Lancet 2004;364:249-256.
7. Department of Health and Office for National Statistics. Statistical bulletin: cervical screening programme, England 1997-98 to 2002-03.
8. Evans DMD, Hudson EA, Brown CL, et al. Terminology in gynaecological cytopathology: report of the working party of the British Society for Clinical Cytology. J Clin Pathol 1986;39:933-944.
9. Buckley, et al. Borderline nuclear changes in cervical smears: guidelines on their recognition and management. J Clin Pathol 1994;47:481-492.
10. Herrington CS. Human papillomavirus (HPV) in gynaecological cytology from molecular biology to clinical testing. Cytopathology 1995;6:176-189.
11. Rana DN, Marshall J, Desai M, et al. Five-year follow-up of women with borderline and mildly dyskaryotic cervical smears. Cytopathology 2004;15:263-270.
12. Cuzick J, Szarewski A, Cubie H, et al. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 2003;362:1871-1876.
13. The ASCUS-LSIL triage (ALTS) group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003;188:1383-1392.
14. Elit L, McLachlin M, Kirk ME, Gary M, Robins R. Management of colposcopy patients with biopsy-proven cervical intraepithelial neoplasia grade 1. J Lower Genital Tract Dis 1999;3:191-195.
15. Borderline Nuclear Changes National Slide Exchange Study Group. Do borderline nuclear changes in gynaecological cytology constitute a reliable reporting category? Cytopathology 2002;13:220-231.
16. Mathers ME, Johnson SJ, Wadehra V. How predictive is a smear suggesting glandular neoplasia? Cytopathology 2002;13:83-91.
17. Waddell C. Glandular neoplasms of the uterine cervix. Chapter 32. In: Gray W, McKee G, editors. Diagnostic cytopathology. 2nd ed. London: Churchill Livingston, 2003.